A new method for quantitative assessment of P-glycoprotein-related multidrug resistance in tumour cells
1996

New Method for Assessing Drug Resistance in Tumor Cells

publication Evidence: moderate

Author Information

Author(s): L Homolyal, Z Hollo, M Mffllerl, EB Mechetner, B Sarkadil

Primary Institution: National Institute of Haematology, Blood Transfusion and Immunology, Budapest, Hungary

Hypothesis

A rapid and quantitative diagnostic method for estimating P-glycoprotein-related multidrug resistance in tumor cells is needed for effective chemotherapy.

Conclusion

The new calcein accumulation assay provides a reliable and sensitive measure of multidrug resistance in tumor cells.

Supporting Evidence

  • The new assay allows for differentiation between drug-sensitive and drug-resistant cells in a short time frame.
  • Calcein AM is a high-affinity substrate for the MDR1 transporter, enhancing the sensitivity of the assay.
  • The method correlates well with the levels of P-glycoprotein expression and drug resistance in various cell lines.

Takeaway

Scientists created a new test to see how well cancer cells can resist drugs, which can help doctors choose better treatments.

Methodology

The study used a calcein accumulation method combined with immunorecognition and drug-resistance studies to assess P-glycoprotein expression and function in various tumor cell lines.

Limitations

The study may not account for non-functional P-glycoprotein or the presence of other drug resistance mechanisms.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication